Adoram Therapeutics SA
Biotechnology · Grand-Lancy, Geneva
Adoram Therapeutics SA is a Swiss biotechnology company based in Grand-Lancy, Canton of Geneva, listed in the Swiss commercial register since 2022 (UID CHE-414.015.961).
Board members & signatories
- Hesham Hamed — Präsident des Verwaltungsrates
- David Pejoski — Mitglied des Verwaltungsrates
Registered purpose
le développement, l'import, l'export et le commerce de produits pharmaceutiques et l'octroi de licences dans ce domaine. D'une manière générale, la société pourra créer des succursales ou des filiales en Suisse et à l'étranger, participer à d'autres entreprises, acquérir ou fonder des entreprises visant un but identique ou analogue, accorder des prêts ou des garanties à des actionnaires ou à des t…
Source: Swiss commercial register (Zefix / SOGC) and Alpintel analysis · Data as of March 2026
What Adoram Therapeutics does
OFFERING
Adoram Therapeutics focuses on developing small molecule drugs that serve as immunotherapies for patients with solid tumors and immune-based diseases. Their lead asset, A2AR NAM, is nearing clinical drug candidate stage and aims to enhance the anti-tumor immune response. This approach seeks to provide alternatives for patients who do not adequately respond to existing immunotherapies.
Unlock the full analysis →Similar companies
- ADC Therapeutics AG — Biotechnology · Epalinges
- TheraPPI Bioscience AG — Biotechnology · Plan-les-Ouates
- TOLREMO therapeutics AG — Pharmaceuticals · Basel
- Molecular Partners AG — Biotechnology · Schlieren
- Alkapharmics GmbH — Pharmaceuticals · Neuchâtel
- CORETAG Therapeutics AG — Pharmaceuticals · Basel
Find every biotechnology company in Switzerland
Alpintel searches all 710,000 Swiss companies with AI — filter by industry, size, revenue, region and ownership in seconds.
family-owned biotechnology companies with 50+ employees…Search →Full profiles from CHF 49/month · Cancel anytime